Literature DB >> 17633082

[Cerebral inhibitory functioning in patients with attention deficit/hyperactivity disorder. I. Analysis of non-target-P300 component in a visual oddball paradigm].

Yuki Inoue1, Masumi Inagaki, Atsuko Gunji, Naomi Kokubo, Makiko Kaga.   

Abstract

The present study was organized to evaluate the cerebral inhibitory function in children with developmental disorders such as attention deficit/hyperactivity disorder (AD/HD) and pervasive developmental disorder (PDD). Target and non-target-P300 event related potential (ERP) in response to stimuli of a visual oddball paradigm was analyzed. Ten children with AD/HD, 10 children with PDD and 10 healthy children were included in the study participants. Target-P300 component was observed in all subjects, which showed predominant amplitudes in Pz electrode. No significant differences were observed in amplitude and latency of target-P300 among three groups. In healthy children, Non-target-P300 component was observed mainly in Cz and Pz electrodes, while children with AD/HD had significantly reduced amplitudes of the component at Cz and children with PDD showed shorter latency at Oz. These results suggest that Non-target-P300 component in visual oddball paradigm possibly reflects the brain function associated with inhibitory processing and there is a relationship between the non-target-P300 potential abnormality and the AD/HD behavior.

Entities:  

Mesh:

Year:  2007        PMID: 17633082

Source DB:  PubMed          Journal:  No To Hattatsu        ISSN: 0029-0831


  2 in total

1.  Attentional responses on an auditory oddball predict false memory susceptibility.

Authors:  John E Kiat; Dianna Long; Robert F Belli
Journal:  Cogn Affect Behav Neurosci       Date:  2018-10       Impact factor: 3.282

2.  Cognitive processing of orientation discrimination in anisometropic amblyopia.

Authors:  Jianglan Wang; Jiao Zhao; Shoujing Wang; Rui Gong; Zhong Zheng; Longqian Liu
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.